#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Haemophagocytic lymphohistiocytosis Head and neck cancer Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Chemical burn Synovitis Prophylaxis against transplant rejection Sjogren's syndrome Still's disease Autoimmune hepatitis Hepatoblastoma Adult T-cell lymphoma/leukaemia refractory Non-renal cell carcinoma of kidney Gastrointestinal neuroendocrine tumour Myelin oligodendrocyte glycoprotein antibody-associated disease Hereditary motor and sensory neuropathy More trials…

    Learn about Rare Diseases

    Arterial tortuosity syndrome Rhabdoid tumour – Basic Information Hypereosinophilic syndrome – Treatment Bronchopulmonary dysplasia – Trials in Disease Primary hyperoxaluria – Life with Disease Paroxysmal nocturnal haemoglobinuria – Diagnostics Encephalitis autoimmune – Trials in Disease Atypical teratoid/rhabdoid tumour of CNS – Treatment Niemann-Pick disease Leukoencephalopathy – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pritelivir Radotinib Dihydrochloride Duvakitug Cefuroxime Axetil Imiglucerase Arginine Testosterone Undecanoate ZALFERMIN Tadalafil Niflumic Acid SODIUM FUSIDATE Topotecan Ddcart‐Cd19 Human Coagulation Factor Vii Sirolimus Gemcitabine Paltusotine Idelalisib Romosozumab Rbl035.2 More therapies…

    Learn about Your Condition

    Colour blindness Idiopathic pulmonary fibrosis Factor IX deficiency Rheumatic disorder Cryoglobulinaemia Peritoneal sarcoma Relapsing multiple sclerosis Endocrine ophthalmopathy Plasma cell myeloma refractory Endometrial cancer stage I Cervix carcinoma stage IV Optic atrophy Large cell lung cancer stage 0 Hypertonic bladder Pleomorphic leiomyosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centrul Medical Dr. Ianosi

Centrul Medical Dr. Ianosi

Bulevardul Carol I nr. 99, Craiova, 200061, Romania

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Namodenoson Treatment in Patients with Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis

    Recruiting

    2 1
    Investigated Drugs:
    • Namodenoson
    Bulgaria Poland Romania

  • Study on Long-term Safety and Effectiveness of ESK-001 for Patients with Moderate to Severe Plaque Psoriasis

    Not recruiting

    3 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Envudeucitinib
    Austria Belgium Bulgaria Czechia Estonia France +7

  • Study on the Effectiveness and Safety of ESK-001 and Apremilast for Patients with Moderate to Severe Plaque Psoriasis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Envudeucitinib
    • Apremilast
    Austria Estonia France Germany Hungary Latvia +3

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!